Assessing metabolomic alterations in age-related macular degeneration (AMD) can provide
insights into its pathogenesis. We compared the metabolomic profiles of the aqueous humor …

The pathogenesis of age-related macular degeneration (AMD), a leading cause of blindness
worldwide, remains only partially understood. This has led to the current lack of accessible …

Purpose To characterize the plasma metabolomic profile of patients with age-related
macular degeneration (AMD) using mass spectrometry (MS). Design Cross-sectional …

Background Age-related macular degeneration (AMD) is a leading disease associated with
blindness. It has a high incidence and complex pathogenesis. We aimed to study the …

Biofluid biomarkers of age-related macular degeneration (AMD) are still lacking, and their
identification is challenging. Metabolomics is well-suited to address this need, and urine is a …

Wet age-related macular degeneration (wAMD) causes central vision loss and represents a
major health problem in elderly people. Here we have used untargeted metabolomics using …

Biomarkers can help unravel mechanisms of disease and identify new targets for therapy.
They can also be useful in clinical practice for monitoring disease progression, evaluation of …

To characterize metabolites and metabolic pathways altered in intermediate and
neovascular age-related macular degeneration (IAMD and NVAMD), high resolution …

The macular neovascular disease is a group disorder with complex pathogenesis of
neovascularization for vision impairment and irreversible blindness, posing great challenges …

Purpose: Age-related macular degeneration (AMD) is one of the leading causes of
blindness among the elderly, and the exact pathogenesis of the AMD remains unclear. The …